Back to Search
Start Over
Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients.
- Source :
-
Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2018 Nov 30; Vol. 2018 (1), pp. 103-109. - Publication Year :
- 2018
-
Abstract
- With the advent new proteasome inhibitors (carfilzomib, ixazomib), new immune-modulatory drugs (pomalidomide), and new monoclonal antibodies (elotuzimab, daratumumab) as approved treatments for myeloma, the therapeutic landscape for this disease has changed. In this chapter, using a case-based approach, I will provide a personal guide of how I approach myeloma therapy in a transplant eligible patient in 2018.<br />Competing Interests: Conflict-of-interest disclosure: S.G. has received research funding and honoraria from Celgene, Sanofi, Amgen, Takeda, Novartis, Miltenyi, Pfizer, JAZZ, and Johnson & Johnson.<br /> (© 2018 by The American Society of Hematology. All rights reserved.)
- Subjects :
- Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized therapeutic use
Back Pain blood
Back Pain diagnosis
Back Pain diagnostic imaging
Back Pain drug therapy
Female
Humans
Ibuprofen administration & dosage
Immunologic Factors therapeutic use
Lumbar Vertebrae diagnostic imaging
Magnetic Resonance Imaging
Middle Aged
Multiple Myeloma blood
Multiple Myeloma diagnostic imaging
Thalidomide analogs & derivatives
Thalidomide therapeutic use
Thoracic Vertebrae diagnostic imaging
Tomography, X-Ray Computed
Multiple Myeloma diagnosis
Multiple Myeloma drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1520-4383
- Volume :
- 2018
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Hematology. American Society of Hematology. Education Program
- Publication Type :
- Academic Journal
- Accession number :
- 30504298
- Full Text :
- https://doi.org/10.1182/asheducation-2018.1.103